Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial

Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial

Abstract Introduction Hidradenitis suppurativa (HS) is a chronic, immune-mediated skin condition characterized by inflammatory lesions that can cause pain, impaired physical activity, and reduced quality of life. This study evaluated the efficacy and safety of risankizumab, a humanized immunoglobuli...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexa B. Kimball (Author), Errol P. Prens (Author), Thierry Passeron (Author), Emanual Maverakis (Author), Irina Turchin (Author), Stefan Beeck (Author), Leonidas Drogaris (Author), Ziqian Geng (Author), Tianyu Zhan (Author), Izabella Messina (Author), Falk G. Bechara (Author)
Format: Book
Published: Adis, Springer Healthcare, 2023-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items